SCHEMBL5492873

SCHEMBL5492873

COc1ccc(/C=C/c2ccc(Cl)cc2)cc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 2/20 0.74
RELA Q04206 3/20 0.67
TRPA1 O75762 1/20 0.65
NFE2L2 Q16236 3/20 0.64
MAOB P27338 2/20 0.64
MAOA P21397 1/20 0.64
CYP1A2 P05177 3/20 0.63
CYP1A1 P04798 3/20 0.63
CYP1B1 Q16678 3/20 0.63
ESR1 P03372 2/20 0.63
PTGS2 P35354 2/20 0.63
ABL1 P00519 1/20 0.63
TTR P02766 1/20 0.63
ABCB1 P08183 1/20 0.63
ALOX5 P09917 1/20 0.63
BCR P11274 1/20 0.63
CYP19A1 P11511 1/20 0.63
NQO2 P16083 1/20 0.63
TUBB4A P04350 1/20 0.63
TUBB P07437 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18416525 1.00 AHR (0.74) AHRRELATRPA1NFE2L2MAOB
SCHEMBL5492879 1.00 AHR (0.74) AHRRELATRPA1NFE2L2MAOB
SCHEMBL17367876 0.91 AHR (0.63) AHRRELATRPA1NFE2L2MAOB
SCHEMBL9580422 0.90 ALDH1A1 (0.70) AHRRELATRPA1NFE2L2MAOB
SCHEMBL9580415 0.90 ALDH1A1 (0.70) AHRRELATRPA1NFE2L2MAOB
SCHEMBL14950253 0.88 RELA (0.81) AHRRELATRPA1NFE2L2CYP1A2
SCHEMBL4881152 0.88 RELA (0.81) AHRRELATRPA1NFE2L2CYP1A2
SCHEMBL13790336 0.88 RELA (0.81) AHRRELATRPA1NFE2L2CYP1A2
SCHEMBL699457 0.88 RELA (0.81) AHRRELATRPA1NFE2L2CYP1A2
SCHEMBL631998 0.88 RELA (0.81) AHRRELATRPA1NFE2L2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9933712-B2 Multi-layer electrophotographic photosensitive member, process cartridge, and image forming apparatus KYOCERA DOCUMENT SOLUTIONS INC. (JP) 2018-04-03 US disclosed
US-9925153-B2 Therapeutic agents for skin diseases and conditions STC.UNM (US) 2018-03-27 US disclosed
CN-107734969-A Molecules having pesticidal utility, and intermediates, compositions and methods related thereto 美国陶氏益农公司 2018-02-23 CN disclosed
CN-107529748-A Molecule with desinsection effectiveness, and relative intermediate, composition and method 美国陶氏益农公司 2018-01-02 CN disclosed
US-9690217-B2 Triarylamine derivative, electrophotographic photosensitive member, and image forming apparatus Kyocera Document Solutions, Inc. (JP) 2017-06-27 US disclosed
US-20170060006-A1 MULTI-LAYER ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS KYOCERA DOCUMENT SOLUTIONS INC. (JP) 2017-03-02 US disclosed
EP-3136175-A1 MULTI-LAYER ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER, METHOD FOR PRODUCING THE SAME, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS Kyocera Document Solutions Inc. (JP) 2017-03-01 EP disclosed
US-9581921-B2 Electrophotographic photosensitive member KYOCERA DOCUMENT SOLUTIONS INC. (JP) 2017-02-28 US disclosed
US-9581921-B2 Electrophotographic photosensitive member KYOCERA DOCUMENT SOLUTIONS INC. (JP) 2017-02-28 US disclosed
US-9494881-B2 Triarylamine derivative and electrophotographic photosensitive member KYOCERA DOCUMENT SOLUTIONS INC. (JP) 2016-11-15 US disclosed
US-20160179020-A1 TRIARYLAMINE DERIVATIVE AND ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER KYOCERA DOCUMENT SOLUTIONS INC. (JP) 2016-06-23 US disclosed
US-20160152552-A1 TRIARYLAMINE DERIVATIVE AND ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER KYOCERA DOCUMENT SOLUTIONS INC. (JP) 2016-06-02 US disclosed
US-20160152552-A1 TRIARYLAMINE DERIVATIVE AND ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER KYOCERA DOCUMENT SOLUTIONS INC. (JP) 2016-06-02 US disclosed
US-20160062253-A1 TRIARYLAMINE DERIVATIVE, ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMEBER, AND IMAGE FORMING APPARATUS KYOCERA DOCUMENT SOLUTIONS INC. (JP) 2016-03-03 US disclosed
US-20160033885-A1 ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER KYOCERA DOCUMENT SOLUTIONS INC. (JP) 2016-02-04 US disclosed
US-20160033885-A1 ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER KYOCERA DOCUMENT SOLUTIONS INC. (JP) 2016-02-04 US disclosed
WO-2015085143-A2 THERAPEUTIC AGENTS FOR SKIN DISEASES AND CONDITIONS STC.UNM (US) 2015-06-11 WO disclosed
US-8980954-B2 Substituted cis- and trans-stilbenes as therapeutic agents STC.UNM (US) 2015-03-17 US disclosed
US-20130178536-A1 SUBSTITUTED CIS- AND TRANS-STILBENES AS THERAPEUTIC AGENTS STC.UNM (US) 2013-07-11 US disclosed
US-20070249647-A1 Substituted CIS- and trans-stilbenes as therapeutic agents REGENTS OF THE UNIVERSITY OF NEW MEXICO 2007-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160062253-A1 TRIARYLAMINE DERIVATIVE, ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMEBER, AND IMAGE FORMING APPARATUS AADAT, PNMT, KMO AHR 262/4885RELA 3692/4885TRPA1 701/4885
US-20160152552-A1 TRIARYLAMINE DERIVATIVE AND ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER TYR, NAT1, CRY1 AHR 85/4885RELA 1907/4885TRPA1 882/4885
US-20160179020-A1 TRIARYLAMINE DERIVATIVE AND ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER CRY1, CRY2, PAH AHR 45/4885RELA 3106/4885TRPA1 592/4885
US-20070249647-A1 Substituted CIS- and trans-stilbenes as therapeutic agents TGFB1, VHL, TMSB10 AHR 858/4885RELA 12/4885TRPA1 1533/4885
US-20130178536-A1 SUBSTITUTED CIS- AND TRANS-STILBENES AS THERAPEUTIC AGENTS PSEN1, TERT, PSEN2 AHR 488/4885RELA 10/4885TRPA1 1056/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.